We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

41 hedge funds and large institutions have $21.6M invested in Gyre Therapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,538% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $16K

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

55% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 11

11% more funds holding

Funds holding: 37 → 41 (+4)

7% more capital invested

Capital invested by funds: $20.2M → $21.6M (+$1.43M)

0.36% more ownership

Funds ownership: 1.72% → 2.08% (+0.36%)

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
11
Closed
2
Calls
$1.06M
Puts
$16K
Net Calls
+$1.05M
Net Calls Change
-$39K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$684K
2
State Street
State Street
Massachusetts
+$284K
3
BlackRock
BlackRock
New York
+$221K
4
Northern Trust
Northern Trust
Illinois
+$110K
5
Goldman Sachs
Goldman Sachs
New York
+$97.1K

Top Sellers

Rank Fund Capital Flow
1
AACP
Advantage Alpha Capital Partners
California
-$227K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$227K
3
Morgan Stanley
Morgan Stanley
New York
-$38.2K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.8K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$7.08K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$10.3K -$77 -6 -0.7%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$10K -$1.97K -154 -16%
AIP
28
Ameritas Investment Partners
Nebraska
$8.26K – – –
Legal & General Group
29
Legal & General Group
United Kingdom
$7.29K – – –
AWM
30
Activest Wealth Management
Florida
$6.45K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$6.11K – – –
AB
32
Amalgamated Bank
New York
$3K – – –
SCM
33
Sterling Capital Management
North Carolina
$2.61K +$2.5K +195 +929%
Nisa Investment Advisors
34
Nisa Investment Advisors
Missouri
$1.02K – – –
FDCDDQ
35
Federation des caisses Desjardins du Quebec
Quebec, Canada
$908 +$960 +75 New
Osaic Holdings
36
Osaic Holdings
Arizona
$496 -$5.12K -400 -91%
PA
37
Parallel Advisors
California
$182 +$192 +15 New
GI
38
GAMMA Investing
California
$145 +$154 +12 New
IA
39
IFP Advisors
Florida
$24 +$26 +2 New
Carson Wealth (CWM LLC)
40
Carson Wealth (CWM LLC)
Nebraska
– -$192 -15 -50%
CPA
41
Capital Performance Advisors
California
– -$75 -6 Closed
DB
42
Danske Bank
Denmark
– -$13 -1 Closed
C
43
Covestor
United Kingdom
– +$13 +1 +17%
1
2

GYRE Hedge Fund Activity: Q4 2024 in Review

41 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q4 2024, worth a combined $21.6M — up 7.1% from $20.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GYRE positions and 2 closed out — a net gain of 4 holders — while 17 added to existing stakes and 11 trimmed.

The largest buyer was UBS Group, adding an estimated $684K. The largest seller was Advantage Alpha Capital Partners, cutting an estimated $227K.

  • 41 institutional investors held Gyre Therapeutics (GYRE) as of Q4 2024, up from 37 in Q3 2024.
  • Funds reported $21.6M of Gyre Therapeutics stock for Q4 2024, up 7.1% quarter-over-quarter.
  • 6 funds opened new Gyre Therapeutics positions in Q4 2024 and 2 closed out, a net change of +4 holders.
  • The largest Gyre Therapeutics buyer in Q4 2024 was UBS Group, an estimated $684K added.
  • The largest Gyre Therapeutics seller in Q4 2024 was Advantage Alpha Capital Partners, an estimated $227K sold.

Based on aggregated 13F filings for Q4 2024.